Anatomical Therapeutic Chemical (ATC) Classification

[ Brite menu | Download htext | Download json ]
    

1st Level  2nd Level  3rd Level  4th Level  5th Level  6th Level 

 A ALIMENTARY TRACT AND METABOLISM
 
 B BLOOD AND BLOOD FORMING ORGANS
   B01 ANTITHROMBOTIC AGENTS
   B02 ANTIHEMORRHAGICS
   B03 ANTIANEMIC PREPARATIONS
   B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
   B06 OTHER HEMATOLOGICAL AGENTS
     B06A OTHER HEMATOLOGICAL AGENTS
       B06AA Enzymes
       B06AB Hem products
       B06AC Drugs used in hereditary angioedema
       B06AX Other hematological agents
         B06AX01 Crizanlizumab
           D11480  Crizanlizumab (USAN/INN) <US>
 
 C CARDIOVASCULAR SYSTEM
 
 D DERMATOLOGICALS
 
 G GENITO URINARY SYSTEM AND SEX HORMONES
 
 H SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS
 
 J ANTIINFECTIVES FOR SYSTEMIC USE
 
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
 
 M MUSCULO-SKELETAL SYSTEM
 
 N NERVOUS SYSTEM
 
 P ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS
 
 R RESPIRATORY SYSTEM
 
 S SENSORY ORGANS
 
 V VARIOUS

[ DRUG | BRITE | KEGG2 | KEGG ]
Last updated: December 6, 2019
According to WHO's ATC 2020

» Japanese version